CannTrust to Launch Three New Recreational Brands: liiv, Synr.g and Xscape

VAUGHAN, ON, May 25, 2018 /CNW

CannTrust® Holdings Inc. (“CannTrust” or the “company”, TSX: TRST), one of Canada’s leading licensed producers, manufacturers and distributors of cannabis, today announced that it will be entering the recreational cannabis market together with the launch of new Brands.

CannTrust will be introducing three dynamic Brands of recreational cannabis, building on its established reputation as the first pharmacist owner/operated producer of medical cannabis in Canada producing quality standardized cannabis products.

“Our team has extensive experience in both the Consumer Goods and Alcohol Industries and has applied this knowledge to the cannabis consumer. As a result, we have created three new exciting Brands, each specifically targeted towards a particular type of consumer” said CannTrust’s CEO, Eric Paul.

While full Brand profiles will be unveiled closer to the legal launch of recreational cannabis, CannTrust is excited to share the following previews:

  • Liiv: Comprised of specifically selected strains with well-known lineages, this product is designed for the educated and experienced consumer. This Brand speaks to consumers who do not require all the bells and whistles, just quality product. Liiv products will come in dried flower, pre rolled joints, oils and capsules.
  • Synr.g: From a dinner party to a night out, or just connecting with friends, these expertly crafted strains are perfect for any social occasion and are targeted to consumers who look forward to breaks from their busy lives. Synr.g products will come in dried flower and pre rolled joints.
  • Xscape: Xscape takes the guesswork out of choosing a strain and is designed to give consumers the confidence that they are selecting the product that fits their needs. Xscape will include strains like “Flix n Chill” and “Walk the Dog”. Xscape will come in dried flower and pre rolled joints.

“Based on our in-depth analysis of the targeted recreational market we carefully curated a selection of strains for each of our Brands and are confident that we have selected the right product mix to appeal to a broad range of both retailers and consumers” said CannTrust’s President, Brad Rogers.

CannTrust will be previewing these Brands at the Lift Expo, Booth 825, May 25 to 27 at the Metro Toronto Convention Centre.

CannTrust supports and awaits the expected passage of the requisite legislation and regulations for the establishment of Canada’s recreational cannabis market.

About CannTrust®

Since its inception in 2014, CannTrust® has led the Canadian market in producing pharmaceutically standardized product.

As a federally regulated licensed producer, CannTrust® brings more than 40 years of pharmacy and healthcare experience to the medical cannabis industry. CannTrust® currently operates a 60,000 square foot state-of-the-art hydroponic facility in Vaughan, Ontario, as well as the recently completed 250,000 square foot Phase 1 redevelopment of its 450,000 square foot Niagara Greenhouse Facility. The Phase 2 expansion is underway and is anticipated to be completed and in cultivation towards the middle of 2018.

CannTrust® is committed to research and innovation, as well as contributing to the growing body of evidence-based research regarding the use and efficacy of cannabis. Our product development teams along with our exclusive global pharma partner, Apotex Inc., are diligently innovating and developing products that will make it easier for patients to use medical cannabis. We support ongoing patient education about medical cannabis and have a compassionate use program to support patients with financial needs.

Forward Looking Statements

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation, which are based upon CannTrust’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy.

Forward-looking information include estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact.

Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, CannTrust does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for CannTrust to predict all such factors. When considering these forward-looking statements, readers should keep in mind the risk factors and other cautionary statements in CannTrust’s Annual Information Form dated March 29, 2018 and filed with the applicable Canadian securities regulatory authorities on SEDAR at The risk factors and other factors noted in CannTrust’s Annual Information Form could cause actual events or results to differ materially from those described in any forward-looking information.

The TSX does not accept responsibility for the adequacy or accuracy of this release.

Copyright © 2017 CannTrust Holdings Inc.

SOURCE CannTrust Holdings Inc.

For further information: CannTrust Holdings Inc., Investor Relations,

Related Links


Since 2013 CannTrust has been delivering standardized products that enable physicians to provide accurate dosage to patients, similar to pharmaceuticals, all while rapidly building capacity and capability to expand into new categories.


Subscribe Now


© CannTrust 2019

Terms & Conditions | Accessibility

Pin It on Pinterest